The Personalized Stem Cells That Could One Day Treat Parkinson’s, Heart Failure, Macular Degeneration
Listen to article
(2 minutes)
Could an injection of lab-cultured brain cells, created from a person's own cells, reverse symptoms of Parkinson's disease? That's an idea that Aspen Neuroscience Inc., a startup based in San Diego, plans to test in human trials later this year.
In patients with Parkinson's, neurons die and lose the ability to make the chemical dopamine, leading to erratic, uncontrollable movements. Aspen Neuroscience will test if the newly injected cells can mature into dopamine producers, stopping the debilitating symptoms of this incurable disease, says Damien McDevitt, the company's chief executive officer. Tests in animals have shown promise, the company says.
13 hours ago
May 6, 2023
May 6, 2023
13 hours ago
May 6, 2023
May 6, 2023
19 hours ago
21 hours ago
May 6, 2023
19 hours ago
20 hours ago
5 hours ago
Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Continue reading your article witha WSJ subscription
Already a subscriber? Sign In